Abstracts - faqs.org

Abstracts

Biological sciences

Search abstracts:
Abstracts » Biological sciences

A novel amidase (half-amidase) for half-amide hydrolysis involved in the bacterial metabolism of cyclic imides

Article Abstract:

An amidase, named 'half-amidase,' that catalyzes the second step of cyclic imide transformation has been reported. It is involved in the half-amide hydrolysis that is part of the bacterial metabolism of cyclic imides, for which it is highly specific.

Author: Soong, Chee-Leong, Ogawa, Jun, Shimizu, Sakayu
Publisher: American Society for Microbiology
Publication Name: Applied and Environmental Microbiology
Subject: Biological sciences
ISSN: 0099-2240
Year: 2000
Bacteria, Protein engineering, Cyclic compounds, Histidine, Amides

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Construction of deoxyriboaldolase-overexpressing Escherichia coli and its application to 2-deoxyribose 5-phosphate synthesis from glucose and acetaldehyde for 2'-deoxyribonucleoside production

Article Abstract:

Results demonstrate that 2-deoxyribose 5-phosphate is produced by deoxyriboaldolase encoding gene of Klebsiella pneumoniae, which is overexpressed in Escherichia coli, in the presence of ATP using glucose and acetaldehyde. Data indicate that under the optimal conditions, 100 millimolar 2-deoxyribose 5-phosphate is produced, which is further transformed to 2'-deoxyribonucleoside.

Author: Ogawa, Jun, Shimizu, Sakayu, Horinouchi, Nobuyuki, Sakai, Takafumi, Kawano, Takako, Matsumoto, Seiichiro, Sasaki, Mie, Mikami, Yoichi
Publisher: American Society for Microbiology
Publication Name: Applied and Environmental Microbiology
Subject: Biological sciences
ISSN: 0099-2240
Year: 2003
Science & research, Analysis, Genetic aspects, Microbiological synthesis, Gene expression, Antisense drugs, Deoxyribonucleotides, Deoxynucleotides

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cyclic-imide-hydrolyzing activity of D-hydantoinase from Blastobacter sp. strain A17p-4

Article Abstract:

A study of the cyclic-imide-hydrolyzing activity of a prokaryotic cyclic-ureide-hydrolyzing enzyme, D-hydantoinase, revealed that its structure, physico-chemical properties and NH2-terminal amino acid sequence similar to other reported bacterial D-hydantoinases. It showed the highest catalytic efficiency toard dihydropyrimidines and was induced by dihydropyrimidines. These imply that the cyclic-imide-hydrolyzing activity of D-hydantoinase might likewise be a general property of bacterial D-hydantoinases identical to dihydropyrimidinase.

Author: Soong, Chee-Leong, Ogawa, Jun, Shimizu, Sakayu, Honda, Michinari
Publisher: American Society for Microbiology
Publication Name: Applied and Environmental Microbiology
Subject: Biological sciences
ISSN: 0099-2240
Year: 1999
Hydrolysis, Enzyme structure-activity relationships, Pyrimidines

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Japan, Physiological aspects, Enzymes
Similar abstracts:
  • Abstracts: Spatial patterns of alkaline phosphatase expression within bacterial colonies and biofilms in response to phosphate starvation
  • Abstracts: Lethality of a heat- and phosphate-catalyzed glucose by-product to Escherichia coli O157:H7 and partial protection conferred by the rpoS regulon
  • Abstracts: Crystal structure of T7 gene 4 ring helicase indicates a mechanism for sequential hydrolysis of nucleotides. Structural analysis of DNA replication fork reversal by RecG
  • Abstracts: Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells
  • Abstracts: Effect of electron donor and solution chemistry on products of dissimilatory reduction of technetium by Shewanella putrefaciens
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.